IL6 and COVID-19: The proportions of CD19+ B, CD4+ T, CD8+ T, and NK cells of patients with COVID‐19 were significantly decreased, and the IL‐6 and IL‐10 levels were significantly increased, all of which were more prominent in critically ill patients.